Finding Description
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, record review, interview, facility policy review, and review of the National Institute of Health guidance, the facility failed to ensure reusable resident nebulizer masks were bagged to prevent the potential for cross contamination of the nebulizer mask. This affected two (Residents #3 and #46) of three residents (Residents #3, #17 and #46) reviewed for respiratory therapy. The facility census was 73.
Findings include:
1. Review of Resident #3's medical record revealed the resident was readmitted on [DATE] with diagnoses including chronic obstructive pulmonary disease (COPD), acute on chronic diastolic congestive heart failure (CHF) and chronic respiratory failure with hypoxia (insufficient oxygen supply at the tissue level).
Review of Resident #3's Annual Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed the resident exhibited intact cognition and had no rejection of care.
Review of physician orders revealed an order dated 08/25/24 for albuterol sulfate solution (bronchodilator that works by relaxing and opening the airways of the lungs) for nebulization (a process where liquid medication is converted into a fine mist and inhaled allowing for direct delivery of medications to the lungs and airways), 5 milligrams (mg)/milliliter (ml), one bullet inhalation every two hours as needed for shortness of breath.
Observation on 03/31/25 at 3:33 P.M. revealed Resident #3's nebulizer mask was sitting on top of the resident's continuous positive airway pressure (CPAP) machine on the bedside table.
Interview on 03/31/25 at 3:43 P.M. with Licensed Practical Nurse (LPN) #861 confirmed Resident #3's nebulizer mask was uncovered and should be covered when not in use to prevent cross contamination of the nebulizer mask.
Observation on 04/03/25 at 6:57 A.M. revealed Resident #3's nebulizer mask was sitting on top of the nebulizer machine uncovered with an empty plastic bag sitting next to it on the bedside table.
Interview on 04/03/25 at 7:00 A.M. with Certified Nursing Assistant (CNA) #815 confirmed Resident #3's nebulizer mask was uncovered and should be covered when not in use to prevent cross contamination of the nebulizer mask.
2. Review of Resident #46's medical record revealed the resident was readmitted on [DATE] with diagnoses including chronic respiratory failure, major depressive disorder and Alzheimer's disease.
Review of Resident #46's Quarterly Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed the resident exhibited moderate cognitive impairment.
Review of Resident #46's physician orders revealed an order dated 11/21/23 for ipratropium-albuterol solution (used for treatment or prevention of tightening of muscles that line the airway), 0.5 mg-3 ml one unit dose inhalation four times a day.
Observation on 03/31/25 at 3:30 P.M. revealed Resident #46's nebulizer mask was uncovered and sitting on top of a baseball cap on the bedside table.
Interview on 03/31/25 at 3:42 P.M. with LPN #861 confirmed Resident #46's nebulizer mask was uncovered and should have been covered when not in use to prevent cross contamination of the nebulizer mask.
Review of facility policy Specific Medication Administration Procedures, dated May 2009, revealed after the administration of medications through a small volume nebulizer was completed, the parts should be dissembled, cleaned, and stored in a clean plastic bag with the resident's name and date.
Review of the National Institute of Health guidance for cleaning and storage of nebulizer parts between uses, dated October 2021, revealed Store nebulizer parts in a dry, clean plastic storage bag. If the nebulizer is used by more than one person, keep each person's medicine cup, mouthpiece or mask, and tubing in a separate, labeled bag to prevent the spread of germs.
Findings include:
1. Review of Resident #3's medical record revealed the resident was readmitted on [DATE] with diagnoses including chronic obstructive pulmonary disease (COPD), acute on chronic diastolic congestive heart failure (CHF) and chronic respiratory failure with hypoxia (insufficient oxygen supply at the tissue level).
Review of Resident #3's Annual Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed the resident exhibited intact cognition and had no rejection of care.
Review of physician orders revealed an order dated 08/25/24 for albuterol sulfate solution (bronchodilator that works by relaxing and opening the airways of the lungs) for nebulization (a process where liquid medication is converted into a fine mist and inhaled allowing for direct delivery of medications to the lungs and airways), 5 milligrams (mg)/milliliter (ml), one bullet inhalation every two hours as needed for shortness of breath.
Observation on 03/31/25 at 3:33 P.M. revealed Resident #3's nebulizer mask was sitting on top of the resident's continuous positive airway pressure (CPAP) machine on the bedside table.
Interview on 03/31/25 at 3:43 P.M. with Licensed Practical Nurse (LPN) #861 confirmed Resident #3's nebulizer mask was uncovered and should be covered when not in use to prevent cross contamination of the nebulizer mask.
Observation on 04/03/25 at 6:57 A.M. revealed Resident #3's nebulizer mask was sitting on top of the nebulizer machine uncovered with an empty plastic bag sitting next to it on the bedside table.
Interview on 04/03/25 at 7:00 A.M. with Certified Nursing Assistant (CNA) #815 confirmed Resident #3's nebulizer mask was uncovered and should be covered when not in use to prevent cross contamination of the nebulizer mask.
2. Review of Resident #46's medical record revealed the resident was readmitted on [DATE] with diagnoses including chronic respiratory failure, major depressive disorder and Alzheimer's disease.
Review of Resident #46's Quarterly Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed the resident exhibited moderate cognitive impairment.
Review of Resident #46's physician orders revealed an order dated 11/21/23 for ipratropium-albuterol solution (used for treatment or prevention of tightening of muscles that line the airway), 0.5 mg-3 ml one unit dose inhalation four times a day.
Observation on 03/31/25 at 3:30 P.M. revealed Resident #46's nebulizer mask was uncovered and sitting on top of a baseball cap on the bedside table.
Interview on 03/31/25 at 3:42 P.M. with LPN #861 confirmed Resident #46's nebulizer mask was uncovered and should have been covered when not in use to prevent cross contamination of the nebulizer mask.
Review of facility policy Specific Medication Administration Procedures, dated May 2009, revealed after the administration of medications through a small volume nebulizer was completed, the parts should be dissembled, cleaned, and stored in a clean plastic bag with the resident's name and date.
Review of the National Institute of Health guidance for cleaning and storage of nebulizer parts between uses, dated October 2021, revealed Store nebulizer parts in a dry, clean plastic storage bag. If the nebulizer is used by more than one person, keep each person's medicine cup, mouthpiece or mask, and tubing in a separate, labeled bag to prevent the spread of germs.